A multidisciplinary team reduces in-hospital clinical complications and mortality in patients with diabetic foot ulcers.
diabetes
diabetic foot
hospitalisation
mortality
multidisciplinary foot team
Journal
Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
26
04
2023
received:
16
03
2023
accepted:
28
05
2023
medline:
11
10
2023
pubmed:
9
7
2023
entrez:
9
7
2023
Statut:
ppublish
Résumé
The current study aims to evaluate the effectiveness of a multidisciplinary diabetic foot team (MDFT) in the management of in-patients affected by diabetic foot problems. The study was a retrospective observational study. Consecutive patients with a diabetic foot problem requiring hospitalisation were included. All patients were managed by a MDFT led by diabetologists according to the guidance. The rate of in-hospital complications (IHCs), major amputation, and survival were recorded at the end of patient's hospitalisation. IHC was defined as any new infection different from wound infection, cardiovascular events, acute renal injury, severe anaemia requiring blood transfusion, and any other clinical problem not present at the assessment. Overall, 350 patients were included. The mean age was 67.9 ± 12.6 years, 254 (72.6%) were males, 323 (92, 3%) showed Type 2 diabetes with a mean duration of 20.2 ± 9.6 years; 224 (64%) had ischaemic diabetic foot ulcers (DFUs) and 299 (85.4%) had infected DFUs. IHCs were recorded in 30/350 (8.6%) patients. The main reasons for IHCs were anaemia requiring blood transfusion (2.8%), pneumonia (1.7%), acute kidney failure (1.1%). Patients with IHCs showed a higher rate of major amputation (13.3 vs. 3.1%, p = 0.02) and mortality (16.7 vs. 0.6%, p < 0.0001) in comparison to those without. Ischaemic heart disease (IHD) and wound duration at the assessment (>1 month) were independent predictors of IHC, whereas IHCs, heart failure, and dialysis were independent predictors of in-hospital mortality. The multidisciplinary management of diabetic foot problems leads to an IHC rate of 8%. The risk of IHCs is higher in patients with IHD and long wound duration.
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3690Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
https://diabetesatlas.org/2022-reports/
Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375. PMID: 28614678. https://doi.org/10.1056/NEJMra1615439
Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719-1724. https://doi.org/10.1016/s0140-6736(05)67698-2
Wu H, Yang A, Lau ESH, et al. Secular trends in rates of hospitalization for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study. Diabetologia. 2020;63(12):2689-2698. https://doi.org/10.1007/s00125-020-05278-2
Morbach S, Furchert H, Gröblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021-2027. https://doi.org/10.2337/dc12-0200
Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes related wounds and amputations worse than cancer? Int Wound J. 2007;4(4):286-287. https://doi.org/10.1111/j.1742-481x.2007.00392.x
Bouillet B, Meloni M, Ahluwalia R. Improving referral of patients with diabetic foot ulcer to specialised diabetes foot care units. J Wound Care. 2021;30(10):782-784. https://doi.org/10.12968/jowc.2021.30.10.782
Meloni M, Izzo V, Giurato L, Lázaro-Martínez JL, Uccioli L. Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: comparison between neuropathic and ischemic ulcers. J Clin Med. 2020;9(6):1780. https://doi.org/10.3390/jcm9061780
Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3266. https://doi.org/10.1002/dmrr.3266
Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol. 2016;69(12):1167. https://doi.org/10.1016/j.rec.2016.11.005
Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3273. https://doi.org/10.1002/dmrr.3273
Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3280. https://doi.org/10.1002/dmrr.3280
Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3276. https://doi.org/10.1002/dmrr.3276
Aiello A, Anichini R, Brocco E, et al. Treatment of peripheral arterial disease in diabetes: a consensus of the Italian societies of diabetes (SID, AMD), radiology (SIRM) and vascular endovascular surgery (SICVE). Nutr Metab Cardiovasc Dis. 2014;24(4):355-369. https://doi.org/10.1016/j.numecd.2013.12.007
Macdonald DB, Hurrell C, Costa AF, et al. Canadian association of radiologists guidance on contrast associated acute kidney injury. Can Assoc Radiol J. 2022;73(3):499-514. https://doi.org/10.1177/08465371221083970
Meloni M, Giurato L, Izzo V, Stefanini M, Gandini R, Uccioli L. Risk of contrast induced nephropathy in diabetic patients affected by critical limb ischemia and diabetic foot ulcers treated by percutaneous transluminal angioplasty of lower limbs. Diabetes Metab Res Rev. 2017;33(3):e2866. https://doi.org/10.1002/dmrr.2866
Ayada G, Edel Y, Burg A, et al. Multidisciplinary team led by internists improves diabetic foot ulceration outcomes a before-after retrospective study. Eur J Intern Med. 2021;94:64-68. https://doi.org/10.1016/j.ejim.2021.07.007
Rubio JA, Aragón-Sánchez J, Jiménez S, et al. Reducing major lower extremity amputations after the introduction of a multidisciplinary team for the diabetic foot. Int J Low Extrem Wounds. 2014;13(1):22-26. https://doi.org/10.1177/1534734614521234
Jiménez S, Rubio JA, Álvarez J, Ruiz-Grande F, Medina C. Trends in the incidence of lower limb amputation after implementation of a Multidisciplinary Diabetic Foot Unit. Endocrinol Diabetes Nutr. 2017;64(4):188-197. https://doi.org/10.1016/j.endinu.2017.02.009
Meloni M, Izzo V, Giurato L, et al. Procalcitonin is a prognostic marker of hospital outcomes in patients with critical limb ischemia and diabetic foot infection. J Diabetes Res. 2019;2019:4312737. https://doi.org/10.1155/2019/4312737
Faglia E, Clerici G, Caminiti M, et al. Mortality after major amputation in diabetic patients with critical limb ischemia who did and did not undergo previous peripheral revascularization Data of a cohort study of 564 consecutive diabetic patients. J Diabetes Complications. 2010;24(4):265-269. https://doi.org/10.1016/j.jdiacomp.2009.02.004
Apelqvist J, Elgzyri T, Larsson J, Löndahl M, Nyberg P, Thörne J. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg. 2011;53(6):1582-1588.e2. https://doi.org/10.1016/j.jvs.2011.02.006
Meloni M, Izzo V, Giurato L, Cervelli V, Gandini R, Uccioli L. Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers. J Clin Transl Endocrinol. 2018;11:31-35. https://doi.org/10.1016/j.jcte.2018.01.002
Meloni M, Bouillet B, Ahluwalia R, et al. Validation of the fast-track model: a simple tool to assess the severity of diabetic foot ulcers. J Clin Med. 2023;12(3):761. https://doi.org/10.3390/jcm12030761
Meloni M, Lazaro-Martínez JL, Ahluwalia R, et al. Effectiveness of fast-track pathway for diabetic foot ulcerations. Acta Diabetol. 2021;58(10):1351-1358. https://doi.org/10.1007/s00592-021-01721-x
Anichini R, Brocco E, Caravaggi CM, et al. SID/AMD Diabetic Foot Study Group. Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group. Nutr Metab Cardiovasc Dis. 2020;30(2):167-178. https://doi.org/10.1016/j.numecd.2019.11.009
Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med. 1986;60(232):763-771.
Edmonds M. The multidisciplinary diabetic-foot clinic. Int J Low Extrem Wounds. 2008;7(2):66-67. https://doi.org/10.1177/1534734608317638
Edmonds M. Multidisciplinary care of the diabetic foot patient with infection. Int J Low Extrem Wounds. 2010;9(1):6-8. https://doi.org/10.1177/1534734610363003
Sanders LJ, Robbins JM, Edmonds ME. History of the team approach to amputation prevention: pioneers and milestones. J Am Podiatr Med Assoc. 2010;100(5):317-334. Erratum in: J Am Podiatr Med Assoc. 2010 Nov-Dec;100(6):529. https://doi.org/10.7547/1000317
Uccioli L, Gandini R, Giurato L, et al. Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic. Diabetes Care. 2010;33(5):977-982. https://doi.org/10.2337/dc09-0831
Zayed H, Halawa M, Maillardet L, Sidhu PS, Edmonds M, Rashid H. Improving limb salvage rate in diabetic patients with critical leg ischaemia using a multidisciplinary approach. Int J Clin Pract. 2009;63(6):855-858. https://doi.org/10.1111/j.1742-1241.2007.01608.x
Whisstock C, Volpe A, Ninkovic S, et al. Multidisciplinary approach for the management and treatment of diabetic foot infections with a resorbable, gentamicin-loaded bone graft substitute. J Clin Med. 2020;9(11):3586. https://doi.org/10.3390/jcm9113586
Bus SA, van Netten JJ, Monteiro-Soares M, Lipsky BA, Schaper NC. Diabetic foot disease:“The Times They are A Changin’”. Diabetes Metab Res Rev. 2020;36(Suppl 1):e3249. https://doi.org/10.1002/dmrr.3249